Skip to main content
logo
Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
149.34
-1.22 (-0.81%)
At close: Sep 4, 2025, 4:00 PM
149.34
0.00 (0.00%)
After-hours: Sep 4, 2025, 7:00 PM EDT

Cardinal Health Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
204.62B204.83B205.05B207.77B210.79B204.88B201.03B195.19B
Pharmaceutical Growth
-2.92%-0.02%2.00%6.45%10.93%11.56%13.07%13.81%
Medical
12.68B12.59B12.55B13.27B13.91B14.56B15.13B15.00B
Medical Growth
-8.82%-13.49%-17.07%-11.49%-7.35%-3.14%-0.66%-3.35%

Profit by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
2.26B2.21B2.12B2.11B2.09B2.11B2.13B2.08B
Pharmaceutical Growth
8.19%4.55%-0.28%1.69%4.40%8.38%16.15%15.60%
Medical
135.00M112.00M93.00M146.00M209.00M244.00M244.00M190.00M
Medical Growth
-35.41%-54.10%-61.89%-23.16%88.29%1,776.92%369.23%123.53%

Profit Margin by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Medical
2.20%1.23%0.56%0.26%1.51%0.64%1.81%1.89%
Pharmaceutical
0.96%1.31%1.04%1.10%0.87%1.15%0.97%0.99%

Operating Expense Breakdown

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Distribution, Selling, General, and Administrative
5.38B5.18B5.14B5.12B5.04B5.03B4.93B4.83B
Distribution, Selling, General, and Administrative Growth
6.81%2.90%4.38%5.90%4.24%6.50%5.26%4.18%
Amortization and Other Acquisition-Related Costs
464.00M408.00M336.00M294.00M284.00M276.00M270.00M278.00M
Amortization and Other Acquisition-Related Costs Growth
63.38%47.83%24.44%5.76%-0.35%-8.91%-12.34%-12.03%
Restructuring and Employee Severance
88.00M130.00M155.00M174.00M175.00M139.00M102.00M91.00M
Restructuring and Employee Severance Growth
-49.71%-6.47%51.96%91.21%84.21%29.91%-16.39%-18.75%
Impairments and (Gain)/Loss on Disposal of Assets, Net
18.00M-7.00M94.00M92.00M630.00M989.00M925.00M1.63B---
Impairments and (Gain)/Loss on Disposal of Assets, Net Growth
-97.14%--89.84%-94.37%-49.60%-15.40%-42.90%-25.90%---
Litigation Charges, Net
-185.00M-126.00M60.00M80.00M79.00M-17.00M-174.00M-370.00M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.